Amanote Research
Register
Sign In
Ustekinumab Fails to Show Efficacy in a Phase III Axial Spondyloarthritis Program: The Importance of Negative Results
Arthritis and Rheumatology
- United Kingdom
doi 10.1002/art.40759
Full Text
Open PDF
Abstract
Available in
full text
Categories
Rheumatology
Allergy
Immunology
Date
January 2, 2019
Authors
Philip Mease
Publisher
Wiley
Related search
Widespread Pain in Axial Spondyloarthritis: Clinical Importance and Gender Differences
Arthritis Research & Therapy
Short Term In-Patient Rehabilitation in Axial Spondyloarthritis - The Results of a 2-Week Program Performed in Daily Clinical Practice
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
Axial Spondyloarthritis
NSAIDs in Axial Spondyloarthritis: To Be Continued…?
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Methods to Improve Efficacy of Intravesical Mitomycin C: Results of a Randomized Phase III Trial
Journal of the National Cancer Institute
Cancer Research
Oncology
Early Axial Spondyloarthritis
Current Opinion in Rheumatology
Rheumatology
Alcohol Consumption as a Predictor of the Progression of Spinal Structural Damage in Axial Spondyloarthritis: Data From the Catholic Axial Spondyloarthritis COhort (CASCO)
Arthritis Research & Therapy
Certolizumab Pegol in the Treatment of Axial Spondyloarthritis
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
Profiling Response to TNF-Inhibitor Treatment in Axial Spondyloarthritis
Arthritis Care and Research
Rheumatology
